ClinicalTrials.govpublic full text
To Assess the Effect of Administration of 2 Formulation of AZD3241 on Blood Concentration in Healthy Volunteers
parkinson's disease, phase 1, pharmacodynamic, biomarkers, pharmacokinetics, extended release formulation, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1009315
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.